- Home
- XENE vs PENN Comparison
XENE vs PENN Comparison
Compare XENE & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | PENN |
|---|---|---|
| Founded | 1996 | 1972 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.8B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | XENE | PENN |
|---|---|---|
| Price | $43.74 | $13.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 18 |
| Target Price | ★ $53.91 | $21.94 |
| AVG Volume (30 Days) | 793.2K | ★ 3.2M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,500,000.00 | ★ $6,823,800,000.00 |
| Revenue This Year | N/A | $7.23 |
| Revenue Next Year | N/A | $3.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $26.74 | $13.24 |
| 52 Week High | $46.60 | $23.08 |
Technical Indicators
Market Signals| Indicator | XENE | PENN |
|---|---|---|
| Relative Strength Index (RSI) | 56.74 | 38.29 |
| Support Level | $42.89 | $13.46 |
| Resistance Level | $44.57 | $14.57 |
| Average True Range (ATR) | 1.42 | 0.49 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 32.63 | 23.99 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.